• Mutual Funds
  • Nippon Mutual Fund
  • Nippon India Pharma Fund (RIDCW)

Formerly Nippon India Pharma DR

Nippon Mutual Fund

Nippon India Pharma Fund (RIDCW)

EquitySectoral / Thematic - Pharma And Healthcare

114.8374

NAV (Jun 18)

28.9%
5 Year CAGR
Scripbox Opinion
Neutral
Click here for top ranked funds in sectoral / thematic - pharma and healthcare mutual funds.

Sectoral / thematic - pharma and healthcare funds provides inflation beating growth over the long term and is suitable for investment objectives with duration of 10-15 years or longer (minimum 5 years).

The pharma benchmark index itself has been a material underperformer over an extended time frame.

Contrary to common perception, this category is also characterised by higher volatility.Investing in these funds will require investors to have a unique insight into the specific areas of investment that these funds focus on.In addition the investor will need to have the ability,inclination and expertise to monitor the prospects closely.Investors are therefore better off investing in diversified funds rather than this category.

Scripbox does not recommend investing in the dividend option of a fund because dividends are taxable at a higher rate than withdrawals.

Our analysis of this fundLearn how we rate funds ->

Fund Size

Category Leader

The fund has been a Category Leader on the Fund Size metric

Outperformance Consistency

Neutral

The performance of the fund on a Outperformance Consistency metric has been Neutral

Invest in this fund
Scripbox Recommended Equity Funds
Want the equity funds that are right for your long term equity investment needs?Learn more

Investment Calculator

Investment Duration5 years

0

Total Investment

0

Wealth Gained

0

Total Corpus Created (₹)

With CAGR of 11.25 % in 5 years

Historical NAV

114.8374

NAV (Jun 18)

Fund Returns

Last 1Y
46.9%
Last 3Y
15.4%
Last 5Y
26.5%
Last 10Y
17.3%
Since Inception
20.9%
6 Month CAGR
18.9%

Scheme Information

Investment Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Expense Ratio
1.82
Launched (20y ago)
Jun 05, 2004
AUM in Crores
7160.933
ISIN
INF204K01943
Lock-in
No Lock-in
Benchmark
BSE Healthcare TR INR
SIP Minimum
1000
Lumpsum Min.
5000
Standard Deviation (3yr)
14.2
Standard Deviation (5yr)
18.3
Beta (3yr)
0.9
Beta (5yr)
0.91
Sharpe Ratio (3yr)
0.693
Sharpe Ratio (5yr)
1.128
YTM
0
Fund Managers

Sailesh Raj Bhan

Fund Manager

Kinjal Desai

Fund Manager

Important Links

Scheme Information Document

Statement of Additional Information

Portfolio Disclosure

Returns Calculator Comparison

of

for

with step up of

AssetReturnsTotal CorpusGainsCAGR
Nippon India Pharma Fund (RIDCW)70%15,60,372 8,27,76028.9%
EPF70% 9,00,761 1,68,1498.50%
Property70% 8,67,662 1,35,0507.00%
PPF70% 8,69,819 1,37,2077.10%
Bank FD70% 8,46,471 1,13,8596.00%
Gold70% 8,46,471 1,13,8596.00%
Savings Bank70% 8,25,950 93,3385.00%

Disclaimer: Products compared like fixed deposits may provide fixed guaranteed returns. Mutual Funds investments are subject to market risk, read all scheme related documents carefully before investing. Past performance is not an indicator of future returns.

Asset allocation and Holdings

Last updated on 2024-06-18

Top Stock Holdings

sun pharmaceuticals industries ltd

13.4%
13.4%

lupin ltd

7.7%
7.7%

divi's laboratories ltd

7.5%
7.5%

cipla ltd

6.3%
6.3%

apollo hospitals enterprise ltd

5.3%
5.3%
See all holdings

Allocation by Sector

healthcare

98.4%
98.4%
See all sectors

Comparison with Equity Funds

Fund NameFund SizeOutperformance Consistency
DSP ELSS Tax Saver Fund (G)
DSP ELSS Tax Saver Fund (G)

₹ 15,161 cr

₹ 19,454 cr

₹ 22,620 cr

₹ 42,669 cr

₹ 63,933 cr

amc-img

About the AMC

Nippon Life India Asset Management Ltd

Nippon Life India Asset Management Ltd manages assets worth 380,402 crores and was set up on 24 February 1995. It's current offering of mutual fund schemes includes 105 equity,425 debt and 71 hybrid funds.amc-img
phone-img022-33031000
Fund NameScripbox Opinion
Till Date CAGR

5.7%

6.9%

5.7%

6.7%

5.7%

5.8%

5.7%

6.7%

5.7%

5.8%

Nippon India Pharma Fund (RIDCW) Review

Nippon India Pharma Fund (RIDCW) is a Sectoral / Thematic - Pharma And Healthcare Equity fund and has delivered an annualised return of 21.5% over a period of 20 years. The fund was previously known as Nippon India Pharma DR. The fund is managed by Nippon Life India Asset Management Ltd. The fund managers are Kinjal Desai, Sailesh Raj Bhan.

Nav of Nippon India Pharma Fund (RIDCW) as of 6/18/2024 is ₹114.84 with the total AUM as of 6/19/2024 is ₹7160.933. With Scripbox you can compare and check the latest nav for all mutual funds in India. Nippon India Pharma Fund (RIDCW) was launched on Jun 05, 2004. The category risk of the fund is Very High Risk.

The minimum SIP amount for Nippon India Pharma Fund (RIDCW) is ₹1000 and you can increase this in multiples of ₹100. In case you want to invest a lump sum, the minimum amount to be invested is ₹5000. Check your estimated returns on mutual funds by using sip calculator.

Nippon India Pharma Fund (RIDCW) is meant for investors with a minimum investment horizon of 5-7 years. Due to the asset class nature, expect volatility in your investments over the short term. The fund is benchmarked to BSE Healthcare TR INR.

Nippon India Pharma Fund (RIDCW) is rated as a 2 fund in Equity and delivered 49.8% returns in the last 1 year. Scripbox provides a compare mutual funds research tool to view a detailed comparison with Nippon India Pharma Fund (RIDCW).

Frequently Asked Questions

What is Nippon India Pharma Fund (RIDCW)?

Nippon India Pharma Fund (RIDCW) is a Sectoral / Thematic - Pharma And Healthcare Equity scheme predominantly investing across Equity instruments with an investment objective to generate wealth over the long term.

How to invest in Nippon India Pharma Fund (RIDCW)?

You can invest in Nippon India Pharma Fund (RIDCW) through AMC, intermediaries, brokers or platforms like Scripbox. To learn step by step process visit how to invest in mutual funds?

What is the minimum sip amount of Nippon India Pharma Fund (RIDCW)?

The minimum sip amount for Nippon India Pharma Fund (RIDCW) is ₹1000. You can invest in multiples of ₹5000.

Is Nippon India Pharma Fund (RIDCW) good to invest in?

As per Scripbox experts, Nippon India Pharma Fund (RIDCW) is a Neutral fund. You can investNippon India Pharma Fund (RIDCW) fund if its investment objective and risk-o-meter matches your investment goals and risk preferences.

What is the expense ratio of the Nippon India Pharma Fund (RIDCW)?

The expense ratio of the Nippon India Pharma Fund (RIDCW) is 1.82% for regular plan.